EW

Edwards Lifesciences Corp

Edwards Lifesciences Corp (EW) has 32 SEC Form 4 filings (72 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 13, 2026.

The most active filer is CVP, TAVR Lippis Daniel J. with 4 filings. Insiders have net sold $5.2M over the trailing 6 months.

  • Industry:Medical - Devices
  • CEO:Bernard J. Zovighian
  • Employees:15,800
  • HQ:Irvine, CA, US
  • IPO:2000-03-27

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$5.2M

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Market Cap

$50.6B

latest known value

Source
Sale$57KJul 10SEC ↗
Sale$57KJul 1SEC ↗
Sale$46KJun 17SEC ↗
BOBO DONALD E JRFirst filing
Sale$2.0MMay 27SEC ↗
Sale$2.8MMay 12SEC ↗
Markowitz WayneFirst filing
Sale$47KMay 12SEC ↗
Lippis Daniel J.First filing
Sale$85KMay 4SEC ↗
Lippis Daniel J.First filing
Sale$86KMay 4SEC ↗

Congress trading EW

See timeline →
  • DRep. Ro KhannaPurchase$1,001 - $15,0002026-05-01

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Related companies

Edwards Lifesciences Corp is in the Manufacturing sector.